
Masimo Receives FDA Clearance for First Pediatric-Specific Patient State Index
Masimo Secures FDA 510(k) Clearance for First Pediatric-Specific Patient State Index, Advancing Brain Monitoring During Pediatric Sedation Masimo, a Danaher company and a global innovator in patient monitoring and specialty diagnostic technologies, has received U.S. Food and Drug Administration (FDA)…













